| Formulary Chapter 3: Respiratory system - Full Chapter
|
| Chapter Links... |
 NICE CG115: Chronic obstructive pulmonary disease in over 16s: diagnosis and management |
| NICE TA10: Guidance on the use of inhaler systems (devices) in children under the age of 5 years with chronic asthma |
| NICE TA138: Inhaled corticosteroids for the treatment of chronic asthma in adults and in children aged 12 years and over |
| NICE TA38: Inhaler devices for routine treatment of chronic asthma in older children (aged 5–15 years) |
 BCICB Asthma Treatment Guidelines - Adolescents 12-17 years old |
| BCICB Asthma Treatment Guidelines - Adults 18+ |
| BCICB Asthma Treatment Guidelines For Children Under 12 |
| BCICB COPD Inhaler Treatment Guidelines |
| BCICB Difficult Asthma Referral Pathway - Adults 18+ |
| Greener Inhaler Guide Switching Information |
| How to improve respiratory control in asthma and COPD |
| COVID-19: information for the respiratory community |
| Details... |
| 03.09 |
Cough preparations |
|
|
Citric acid (oral presentations)
|
Formulary
|
|
|
|
Methadone Hydrochloride
(oral solution and tablet)
|
Formulary
|
For use in palliative care only
|
|
|
Methadone Hydrochloride (Physeptone ®)
(solution for Injection)
|
Formulary
|
For Palliative care use only
|
|
|
Methadone Hydrochloride oral solution (Methadose ®)
|
Formulary
|
For Palliative care use only
|
|
|
Methadone Hydrochloride oral solution (Metharose ®)
|
Formulary
|
For Palliative care use only
|
|
|
Methadone Hydrochloride oral solution (Physeptone ®)
|
Formulary
|
For Palliative care use only
|
|
|
Methadone Linctus
|
Formulary
|
For Palliative care use only
|
|
|
Morphine modified release capsule (Zomorph®)
|
Formulary
|
For Palliative care use only
|
|
|
Morphine modified release tablet (MST Continus ®)
|
Formulary
|
For Palliative care use only
|
|
|
Morphine oral solution
|
Formulary
|
For Palliative care use only
|
|
|
Morphine oral solution
(Oramorph ®)
|
Formulary
|
For Palliative care use only
|
|
|
Morphine solution for infusion
|
Formulary
|
For Palliative care use only
|
|
|
Morphine solution for injection
|
Formulary
|
For Palliative care use only
|
|
|
Morphine tablet (Sevredol®)
|
Formulary
|
For Palliative care use only
|
|
|
Pholcodine Linctus, BP
|
Formulary
|
OTC preparation suitable for self-care/purchase if appropriate
|
Conditions for which over the counter items should not routinely be prescribed in primary care: Guidance for CCGs
|
Pholcodine Linctus, Strong, BP
|
Formulary
|
OTC preparation suitable for self-care/purchase if appropriate
|
|
|
| 03.09.01 |
Cough suppressants |
|
|
| 03.09.01 |
Palliative care |
|
|
| 03.09.02 |
Expectorant and demulcent cough preparations |
|
|
Simple Linctus, BP
|
Formulary
|
OTC preparation suitable for self-care/purchase if appropriate
|
Conditions for which over the counter items should not routinely be prescribed in primary care: Guidance for CCGs
|
Simple Linctus, Paediatric BP
|
Formulary
|
OTC preparation suitable for self-care/purchase if appropriate
|
Conditions for which over the counter items should not routinely be prescribed in primary care: Guidance for CCGs
|
| .... |
| Non Formulary Items |
Ammonia and Ipecacuanha Mixture BP
|
Non Formulary
|
|
|
|
Benzoin tincture, compound (Friars Balsamsup>®)
|
Non Formulary
|
|
|
|
Codeine linctus BP
|
Non Formulary
|
|
|
|
Codeine Linctus, Paediatric BP
|
Non Formulary
|
|
|
|
Codeine phosphate (Galcodine®)
|
Non Formulary
|
|
|
|
Codeine phosphate (oral presentations)
|
Non Formulary
|
|
|
|
Codeine phosphate solution for injection
|
Non Formulary
|
|
|
|
Dextromethorphan / quinidine (Nuedexta®)
|
Non Formulary
|
|
|
|
Eucalyptus with menthol
|
Non Formulary
|
|
|
|
Eucalyptus with menthol Inhalation vapour
|
Non Formulary
|
|
|
|
Morphine modified release capsule (MXL®)
|
Non Formulary
|
|
|
|
Morphine modified release tablet (Morphgesic ®)
|
Non Formulary
|
|
|
|
Pholcodine oral solution (Covonia®)
|
Non Formulary
|
|
|
|
Pholcodine oral solution (Galenphol ®)
|
Non Formulary
|
|
|
|
| |
Key |
 |
Restricted Drug |
 |
Unlicensed |
|
|
Link to adult BNF
|
|
|
Link to children's BNF
|
|
|
Link to SPCs
|
|
Cytotoxic Drug |
|
Controlled Drug |
|
|
High Cost Medicine |
|
Cancer Drugs Fund |
|
NHS England |
|
Homecare |
|
ICB |
|
Low carbon footprint |
|
Medium carbon footprint |
|
High carbon footprint |
|
| Status |
Description |
|
Medicines which are suitable for initiation and maintenance prescribing by primary and secondary care clinicians. These medicines should be initiated and prescribed within their licensed indications |
|
Amber Specialist Initiation: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing when appropriate. This may be supported by a RICaD, annotated within the formulary entry. |
|
Amber Shared Care: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing, in accordance with an ESCA, annotated within the formulary entry. |
|
Amber Specialist Recommendation: Initiation and maintenance of prescribing in Primary Care following recommendation from a specialist. |
|
Medicines for initiation and maintenance prescribing by Specialists (hospital or GPs with Special Interest) only |
|
Positive NICE TA and /or awaiting local clarification on place in therapy; Please contact your Medicines Optimisation team for more information. |
|
Non-formulary Medicines which APC/Trust DTC has actively reviewed and do not recommend for use. |
|
Check Notes as varies across the area |
|
|
|
